Lazuriton Nano Biotechnology (U.S.A.) Inc.: cash_and_restricted_cash
| Value | {"amount": 1348, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | Lazuriton Nano Biotechnology (U.S.A.) Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:07:32.781743+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/45f82f42-b7e1-4f1a-b764-72be1152c32a
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-23-000452Retrieved: 2026-08-19T17:07:32.781743+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001666178/cash-and-restricted-cash/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/45f82f42-b7e1-4f1a-b764-72be1152c32a
History
- no predecessors — first report